# COSELA
> **NDA214200** · New Drug Application · Sponsor: PHARMACOSMOS · Approved 2021-02-12
## Drug
- **FDA Application Number:** NDA214200
- **Application type:** New Drug Application
- **Brand name:** COSELA
- **Generic name:** TRILACICLIB
- **Active ingredients:** TRILACICLIB DIHYDROCHLORIDE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** PHARMACOSMOS
- **Manufacturer:** G1 Therapeutics, Inc.
- **First approval:** 2021-02-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214200)
---
*AI Analytics · CC0 1.0*